Publications by authors named "Samar Issa"

Claim this Profile
M
Minimalist, bioinspired and sensorial emulsion based on a Ca double cone vector system using Design of Experiment (DoE).
Marc Lavarde, Marjorie Lassalle, Solène Gouot, Ysaline Corroyer, Clara Marceau, Samar Issa

Int J Cosmet Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of benzophenone-3 release from clay minerals or organosilicates for sun protection formulation.
Saddam Charaabi, Samar Issa, Anne-Marie Pensé-Lhéritier, Marc Le Borgne

Int J Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.
Jacoline E C Bromberg, Samar Issa, Bronno van der Holt, Matthijs van der Meulen, Linda Dirven

Neuro Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse large B-cell lymphoma at risk of secondary CNS involvement: The inefficacy of intravenous high-dose methotrexate CNS prophylaxis and the importance of baseline cerebrospinal fluid analysis.
Rory Bennett, Anna Ruskova, Christin Coomarasamy, Edward Theakston, Leanne Berkahn, Samar Issa

Am J Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsive Sensory Evaluation to Develop Flexible Taste-Masked Paediatric Primaquine Tablets against Malaria for Low-Resource Settings.
Sejal R Ranmal, Marc Lavarde, Elodie Wallon, Samar Issa, Walter R Taylor

Pharmaceutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A misdiagnosed case of a 150-cm umbilical cord coiled twice around the fetal neck with a true cord knot: A rare Syrian case report.
Majd Hanna, Nafiza Martini, Yara Deeb, Wissam Mahmoud, Samar Yhia Issa

SAGE Open Med Case Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.
Matthijs van der Meulen, Linda Dirven, Esther J J Habets, Katerina Bakunina, Marion Smits, Samar Issa

Neuro Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
Matthijs van der Meulen, Linda Dirven, Katerina Bakunina, Martin J van den Bent, Samar Issa

J Neurooncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience.
Katharine L Lewis, Collin K Chin, Kate Manos, John Casey, Nada Hamad, Samar Issa

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extent of radiological response does not reflect survival in primary central nervous system lymphoma.
Matthijs van der Meulen, Alida A Postma, Marion Smits, Katerina Bakunina, Monique C Minnema, Samar Issa

Neurooncol Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bing-Neel syndrome presenting as isolated CNS lymphoplasmacytic lymphoma: A case report and review of the literature.
Brian T Grainger, Samar Issa

J Clin Neurosci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbazole scaffolds in cancer therapy: a review from 2012 to 2018.
Samar Issa, Anthony Prandina, Nicolas Bedel, Pål Rongved, Saïd Yous

J Enzyme Inhib Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
Andreas M Schmitt, Amanda K Herbrand, Christopher P Fox, Katerina Bakunina, Jacoline E C Bromberg, Samar Issa

Hematol Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study.
Ian W Flinn, Richard van der Jagt, Brad Kahl, Peter Wood, Tim Hawkins, Samar Issa

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Jacoline E C Bromberg, Samar Issa, Katerina Bakunina, Monique C Minnema, Tatjana Seute

Lancet Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary idiopathic CNS non-amyloidogenic light chain deposition disease complicated by treatment-resistant focal seizure disorder.
Brian T Grainger, Samar Issa, Neil E Anderson

J Clin Neurosci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.
Jorge J Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Samar Issa

Blood· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obese non-Hodgkin lymphoma patients tolerate full uncapped doses of chemotherapy with no increase in toxicity, and a similar survival to that seen in nonobese patients.
Henry Chan, Sharon Jackson, Jessica McLay, Angela Knox, Jae Lee, Samar Issa

Leuk Lymphoma· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma.
John M Burke, Richard H C van der Jagt, Brad S Kahl, Peter Wood, Tim E Hawkins, Samar Issa

Clin Lymphoma Myeloma Leuk· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute transient global ventricular dysfunction as the presenting symptom of anaplastic large-cell lymphoma.
Henry Siu Him Chan, Samar Issa

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds.
Zouhair Bouaziz, Samar Issa, Jacques Gentili, Andreas Gratz, Andre Bollacke

J Enzyme Inhib Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.
David T Yeung, Michael P Osborn, Deborah L White, Susan Branford, Jodi Braley, Samar Issa

Blood· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.
Ian W Flinn, Richard van der Jagt, Brad S Kahl, Peter Wood, Tim E Hawkins, Samar Issa

Blood· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of microRNAs in cancer metastasis.
Juliette M C Bouyssou, Salomon Manier, Daisy Huynh, Samar Issa, Aldo M Roccaro

Biochim Biophys Acta· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is rheumatoid arthritis a B-cell haematological disease with a predilection for the joints? Following the B cell thread to its logical conclusion.
Fiona M McQueen, Samar Issa

Med Hypotheses· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis